Posts by: Iqra Mumal

cystic fibrosis, News

ELITechGroup Biomedical Systems has released a new, advanced version of its Macroduct system, called the Macroduct Advanced Sweat Collection System, which allows for improved standardized sweat testing for the diagnosis ... Read more

August 13, 2018August 14, 2018

Airway Clearance Vests Fail to Show Measurable Lung Benefits in Short Term, Study Reports

cystic fibrosis, News

A clinical study into high-frequency chest wall oscillation vests — assessing their short-term impact on standard measures of lung function before and during use — challenges the view that these devices ... Read more

August 1, 2018August 1, 2018

Specific Gene Mutation Causes Severe CF in Georgian Jewish Patients, Study Reports

cystic fibrosis, News

The Q359K/T360K gene mutation, which is commonly found in Jewish patients of Georgian descent, is associated with a particularly severe cystic fibrosis (CF) phenotype, according to researchers. Their study, ... Read more

July 10, 2018July 10, 2018

Azithromycin Added to Standard Therapy for P. Aeruginosa Infection Reduces Lung Exacerbations, Trial Finds

cystic fibrosis, News

Adding azithromycin to the standard antibiotic treatment for early Pseudomonas aeruginosa infections is associated with fewer pulmonary exacerbations in children with cystic fibrosis (CF), results from a Phase 3 trial ... Read more

March 1, 2018March 1, 2018

Early Growth Patterns Affect CF Children’s Lung Function at Age 12, Study Shows

cystic fibrosis, News

Children with cystic fibrosis who are able to recover from below-normal growth in their first two years are more likely to achieve normal growth and better lung condition by ... Read more

February 12, 2018February 12, 2018

2 CF Case Reports Show Successful Use of GM-CSF for Treating Nontuberculous Mycobacteria

cystic fibrosis, News

Savara Pharmaceuticals announced the publication of two case reports demonstrating that inhaled granulocyte-macrophage colony stimulating factor (GM-CSF) either eradicated or dramatically reduced Mycobacterium abscessus (M. abscessus) infection, improved clinical outcomes, ... Read more

January 26, 2018January 26, 2018

Humanigen’s Inflammation Therapy Is Only Modestly Effective in CF Patients with an Infection, Trial Shows

cystic fibrosis, News

Humanigen’s anti-inflammatory therapy KB001-A is safe but only modestly effective in cystic fibrosis patients with a Pseudomonas aeruginosa bacteria infection, a Phase 2 clinical trial indicates. In addition to displaying limited ability to ... Read more

January 2, 2018January 2, 2018

Introduction of New Therapies Affects Pregnancy Rates in Women With CF, Study Reports

cystic fibrosis, News

The overall rate at which women with cystic fibrosis are becoming pregnant dropped slightly in recent years — coinciding with the introduction of CFTR modulators and the clinical trials ... Read more

November 6, 2017November 6, 2017

#NACFC2017 – Two Phase 3 Studies of Tezacaftor/Ivacaftor Combo Show Positive Results in CF Patients

cystic fibrosis, News

Vertex Pharmaceuticals, a clinical-stage biopharmaceutical company, recently announced that two Phase 3 studies evaluating its tezacaftor/ivacaftor combination therapy have shown statistically significant and clinically meaningful improvements in lung function in ... Read more

November 3, 2017November 3, 2017

Corbus Pharmaceuticals Receives Anabasum Patent for Inflammatory, Fibrotic Diseases

cystic fibrosis, News

Corbus Pharmaceuticals recently announced that the U.S. Patent and Trademark Office has issued a patent for the use of anabasum, the company’s lead therapy candidate for the treatment of inflammatory ... Read more

Posts by: Iqra Mumal

Iqra Mumal

ELITechGroup Launches Improved Macroduct Sweat Test for Cystic Fibrosis Diagnosis

Airway Clearance Vests Fail to Show Measurable Lung Benefits in Short Term, Study Reports

Specific Gene Mutation Causes Severe CF in Georgian Jewish Patients, Study Reports

Azithromycin Added to Standard Therapy for P. Aeruginosa Infection Reduces Lung Exacerbations, Trial Finds

Early Growth Patterns Affect CF Children’s Lung Function at Age 12, Study Shows

2 CF Case Reports Show Successful Use of GM-CSF for Treating Nontuberculous Mycobacteria

Humanigen’s Inflammation Therapy Is Only Modestly Effective in CF Patients with an Infection, Trial Shows

Introduction of New Therapies Affects Pregnancy Rates in Women With CF, Study Reports

#NACFC2017 – Two Phase 3 Studies of Tezacaftor/Ivacaftor Combo Show Positive Results in CF Patients

Corbus Pharmaceuticals Receives Anabasum Patent for Inflammatory, Fibrotic Diseases

Pin It on Pinterest